| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Elanco verkündet positive Studienergebnisse für Zenrelia | 13 | Investing.com Deutsch | ||
| Mi | Elanco announces positive study results for Zenrelia | 3 | Investing.com | ||
| Mi | Elanco Animal Health Inc - 8-K, Current Report | 3 | SEC Filings | ||
| 08.10. | US FDA approves Elanco's treatment for parasitic infections in dogs | 8 | Reuters | ||
| 07.10. | Elanco gains FDA approval for Credelio Quattro parasiticide for dogs | 3 | Seeking Alpha | ||
| 07.10. | Elanco's Credelio Quattro gets FDA nod for broad parasite protection | 2 | Investing.com | ||
| 07.10. | Elanco Animal Health: Elanco Receives FDA Approval for Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose | 58 | PR Newswire | Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is the first and only canine oral parasiticide to protect against six parasites, including fleas, ticks, heartworms... ► Artikel lesen | |
| 30.09. | Elanco-Aktien stabil, während Analyst nach Zenrelia-Daten Bewertung bekräftigt | 7 | Investing.com Deutsch | ||
| 30.09. | Elanco shares hold as analyst reiterates on Zenrelia data | 4 | Investing.com | ||
| 20.09. | Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy | 6 | Benzinga.com | ||
| 20.09. | Elanco stock holds Neutral rating amid Zenrelia label review | 11 | Investing.com | ||
| 20.09. | Elanco-Aktie behält neutrales Rating während der Überprüfung des Zenrelia-Labels | 4 | Investing.com Deutsch | ||
| 19.09. | Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews | 4 | Benzinga.com | ||
| 19.09. | Elanco's Zenrelia approved for canine dermatitis treatment | 1 | Investing.com | ||
| 19.09. | US FDA approves Elanco's skin disease treatment for dogs | 1 | Reuters | ||
| 19.09. | Stifel hält an Kaufempfehlung für Elanco-Aktien fest | 4 | Investing.com Deutsch | ||
| 19.09. | FDA approves Elanco's dermatitis treatment for dogs | 1 | Reuters | ||
| 19.09. | Elanco rises on FDA approval for Zenrelia | 3 | Seeking Alpha | ||
| 19.09. | Stifel maintains Buy rating on Elanco shares with no target price change | 3 | Investing.com | ||
| 19.09. | Elanco falls after Morgan Stanley downgrades to 'equal-weight' | 5 | Reuters |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 538 |
| NVIDIA | 534 |
| BYD | 421 |
| BAYER | 395 |
| TUI | 361 |
| NEL | 322 |
| ASML | 314 |
| THYSSENKRUPP | 306 |
| SUPER MICRO COMPUTER | 250 |
| VARTA | 250 |
| PLUG POWER | 234 |
| COMMERZBANK | 220 |
| DEUTSCHE BANK | 209 |
| BARRICK GOLD | 207 |
| TESLA | 195 |
| RHEINMETALL | 181 |
| LITHIUM ENERGI EXPLORATION | 177 |
| BIONTECH | 165 |
| DEUTSCHE TELEKOM | 165 |
| RWE | 161 |
| JINKOSOLAR | 156 |
| ALLIANZ | 155 |
| MERCEDES-BENZ | 153 |
| DEUTSCHE LUFTHANSA | 152 |
| PALANTIR TECHNOLOGIES | 142 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
